Items without sitelinks
Showing below up to 50 results in range #11,351 to #11,400.
- purine ribonucleotide biosynthetic process (Q10899)
- GMP biosynthetic process (Q10898)
- carbon-nitrogen ligase activity, with glutamine as amido-N-donor (Q10897)
- GMP synthase (glutamine-hydrolyzing) activity (Q10896)
- GMP synthase activity (Q10895)
- GMP(2-) (Q10894)
- oxidoreductase activity, acting on other nitrogenous compounds as donors (Q10893)
- oxidoreductase activity, acting on other nitrogenous compounds as donors, with NAD or NADP as acceptor (Q10892)
- GMP reductase activity (Q10891)
- hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (Q10890)
- deaminase activity (Q10889)
- adenosine-phosphate deaminase activity (Q10888)
- AMP deaminase activity (Q10887)
- IMP(2-) (Q10886)
- ligase activity (Q10885)
- ligase activity, forming carbon-nitrogen bonds (Q10884)
- adenylosuccinate synthase activity (Q10883)
- GDP(3-) (Q10882)
- GTPase activity (Q10881)
- GTP(4-) (Q10880)
- (deoxy)nucleoside phosphate kinase activity, GTP as phosphate donor (Q10879)
- gastroenterology (Q10878)
- gastrointestinal system disease (Q10877)
- digestive sign (Q10876)
- vomiting (Q10875)
- chemiotherapy (Q10874)
- disease of cellular proliferation (Q10873)
- carcinogenesis (Q10872)
- oncology and carcinogenesis (Q10871)
- oncology (Q10870)
- treatment of cancer (Q10869)
- chemotherapy (Q10868)
- cancer signs and symptoms (Q10867)
- cancer pain (Q10866)
- organotherapy (Q10865)
- opotherapy (Q10864)
- hormone therapy (Q10863)
- hormones, hormone substitutes, and hormone antagonists (Q10862)
- chemical messenger (Q10861)
- hormone (Q10860)
- peptide hormone (Q10859)
- hexamer (Q10858)
- maintenance of location in cell (Q10857)
- cell therapy (Q10856)
- biotherapy (Q10855)
- intellectual and scientific professionals (Q10854)
- business and administration professionals (Q10853)
- businessperson (Q10852)
- medical representative (Q10851)
- pharmaceutical marketing (Q10850)